首页> 美国卫生研究院文献>Journal of Medical Genetics >Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus.
【2h】

Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus.

机译:LDL受体基因中的四种DNA多态性:它们的遗传关系以及在LDL受体基因座变异研究中的用途。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have studied four different restriction fragment length polymorphisms (RFLPs) for the LDL receptor gene, detected using the restriction enzymes StuI, PvuII, ApaLI, and NcoI, in normal subjects and in patients with familial hypercholesterolaemia (FH) from London. Significant linkage disequilibrium was detected between all four RFLPs. Used together they give a polymorphism information content (PIC) of greater than 0.7 which makes them useful for studying the inheritance of the LDL receptor gene in more than 70% of families with FH. The NcoI and ApaLI RFLPs were found to be the most useful, giving a combined PIC value of 0.6. The allele frequencies of all four polymorphisms were compared in the normal and FH groups and the frequency of the rarer N2 allele of the NcoI RFLP was found to be significantly higher in the FH group. This suggests that a mutation has occurred on the rare NcoI N2 allele and that it may be making a significant contribution to the defects causing FH in this patient group. We have also used these RFLPs to look for evidence that variation at the LDL receptor gene locus contributes to the determination of cholesterol levels in the normal population. People with different RFLP genotypes do not have significantly different levels of serum total or LDL cholesterol. At present we have no evidence that variation at this locus may be determining cholesterol levels in the non-FH population.
机译:我们研究了在正常受试者和来自伦敦的家族性高胆固醇血症(FH)患者中使用限制酶StuI,PvuII,ApaLI和NcoI检测到的LDL受体基因的四种不同的限制性片段长度多态性(RFLP)。在所有四个RFLP之间检测到显着的连锁不平衡。一起使用,它们提供的多态性信息含量(PIC)大于0.7,这使它们可用于研究超过70%的FH家庭中LDL受体基因的遗传。发现NcoI和ApaLI RFLP最有用,组合PIC值为0.6。在正常组和FH组中比较了所有四个多态性的等位基因频率,发现FH组中NcoI RFLP的罕见N2等位基因的频率明显更高。这表明在罕见的NcoI N2等位基因上已发生突变,并且可能对该患者组中引起FH的缺陷做出了重要贡献。我们还使用了这些RFLP来寻找证据,证明LDL受体基因位点的变异有助于确定正常人群中的胆固醇水平。具有不同RFLP基因型的人的血清总胆固醇或LDL胆固醇水平没有显着差异。目前,我们尚无证据表明该基因座的变异可能决定了非FH人群的胆固醇水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号